|
HNRNPK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.27680000092812E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.51697999999367E-05 |
| Normal-vs-Stage2 |
5.92769999999687E-05 |
| Normal-vs-Stage3 |
3.08040000174259E-08 |
| Normal-vs-Stage4 |
1.42389999790993E-08 |
| Stage1-vs-Stage2 |
4.136000E-01 |
| Stage1-vs-Stage3 |
7.741500E-02 |
| Stage1-vs-Stage4 |
2.866300E-02 |
| Stage2-vs-Stage3 |
6.722800E-01 |
| Stage2-vs-Stage4 |
4.415800E-01 |
| Stage3-vs-Stage4 |
6.334000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.19580000135633E-08 |
| Normal-vs-AfricanAmerican |
5.616100E-02 |
| Normal-vs-Asian |
1.360680E-04 |
| Caucasian-vs-AfricanAmerican |
9.318300E-02 |
| Caucasian-vs-Asian |
5.838800E-01 |
| AfricanAmerican-vs-Asian |
2.680800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.07100003602312E-09 |
| Normal-vs-Female |
1.04580000004351E-06 |
| Male-vs-Female |
1.052410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.01310000000188E-05 |
| Normal-vs-Age(41-60Yrs) |
2.9582000005135E-07 |
| Normal-vs-Age(61-80Yrs) |
8.48519998708497E-09 |
| Normal-vs-Age(81-100Yrs) |
5.364500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.077000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.201900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.428400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.005600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.325800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.836200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.172100E-02 |
| Classical-VS-Follicular |
4.181800E-03 |
| Classical-VS-Other |
2.480600E-01 |
| Classical-VS-Normal |
2.11959999999456E-05 |
| Tall-VS-Follicular |
7.029400E-01 |
| Tall-VS-Other |
8.051800E-01 |
| Tall-VS-Normal |
3.66399999995881E-06 |
| Follicular-VS-Other |
9.782000E-01 |
| Follicular-VS-Normal |
1.59389999976334E-07 |
| Other-VS-Normal |
6.001500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.66529997861431E-09 |
| Normal-vs-N1 |
3.82269999987805E-07 |
| N0-vs-N1 |
5.236200E-01 |
|
|
